Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 3.200
+0.060 (1.91%)
Nov 28, 2025, 5:31 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 119.68 million as of November 28, 2025. Its market cap has decreased by -36.34% in one year.
Market Cap
119.68M
Enterprise Value
16.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.20
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 119.68M, a decrease of -71.91%. That is a compound annual growth rate of -10.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 119.68M | -20.04% |
| Dec 30, 2024 | 149.66M | 32.42% |
| Dec 29, 2023 | 113.02M | -43.62% |
| Dec 30, 2022 | 200.48M | -65.16% |
| Dec 30, 2021 | 575.43M | -4.85% |
| Dec 30, 2020 | 604.78M | 60.28% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 264.79B |
| Novartis AG | 200.78B |
| Lonza Group AG | 38.40B |
| Galderma Group AG | 37.87B |
| Alcon | 31.41B |
| Sandoz Group AG | 24.20B |
| Straumann Holding AG | 14.91B |
| Sonova Holding AG | 11.99B |